Oliver Dolan Sells Shares of KRRO $KRRO
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Oliver Dolan, Senior Vice President, Finance at Korro Bio, Inc. ($KRRO), sold 3,383 shares at an average price of $10.83, for a total transaction of $36,637.89. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Korro Bio, Inc. Stock Down 17.4%
Shares of Korro Bio, Inc. ($KRRO) traded around $10.66 on Wednesday, down 17.4% for the day.
Korro Bio, Inc. Earnings
Analysts Set New Price Targets
About Korro Bio, Inc.
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Get Korro Bio, Inc. alerts
New 13F filings, insider trades, and analyst moves on $KRRO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.